Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
John M.S. Bartlett(Edinburgh Cancer Research), Daniel Rea(University Hospitals Birmingham NHS Foundation Trust), Luc Dirix(GZA Ziekenhuizen Campus Sint-Augustinus), Cornelis J.�H. van de Velde(Leiden University Medical Center), Cassandra Brookes(National and Kapodistrian University of Athens), Margaret Grant(National and Kapodistrian University of Athens), Elma Meershoek‐Klein Kranenbarg(Leiden University Medical Center), Christos Markopoulos(Beth Israel Deaconess Medical Center), D. G. Kieback(National and Kapodistrian University of Athens), Hein Putter, Charlene Kay(National and Kapodistrian University of Athens), Fiona Campbell(University of Birmingham), Caroline Seynaeve(Radboud University Nijmegen), E.T.M. Hille(Leiden University), Elizabeth A. Mallon(National and Kapodistrian University of Athens), Lucinda Billingham(University Hospitals Birmingham NHS Foundation Trust), Tammy Robson(National and Kapodistrian University of Athens), Annette Hasenburg(National and Kapodistrian University of Athens)
Cited by 199
Related Papers
Persistent epigenetic differences associated with prenatal exposure to famine in humans
|Proceedings of the National Academy of Sciences|2008|3k
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k